Rakusa, Martin ORCID: 0000-0003-4433-3985, Ozturk, Serefnur, Moro, Elena, Helbok, Raimund, Bassetti, Claudio L., Beghi, Ettore ORCID: 0000-0003-2542-0469, Bereczki, Daniel ORCID: 0000-0002-8374-0500, Bodini, Benedetta ORCID: 0000-0001-8010-1220, Di Liberto, Giovanni, Jenkins, Thomas M., Macerollo, Antonella, Maia, Luis F., Martinelli-Boneschi, Filippo, Pisani, Antonio, Priori, Alberto, Sauerbier, Anna, Soffietti, Riccardo, Taba, Pille, von Oertzen, Tim J., Zedde, Marialuisa, Crean, Michael, Burlica, Anja, Cavallieri, Francesco ORCID: 0000-0001-5836-1982 and Sellner, Johann (2022). COVID-19 vaccination hesitancy among people with chronic neurological disorders: A position paper. Eur. J. Neurol., 29 (8). S. 2163 - 2173. HOBOKEN: WILEY. ISSN 1468-1331

Full text not available from this repository.

Abstract

Background and purpose Health risks associated with SARS-CoV-2 infection are undisputed. Moreover, the capability of vaccination to prevent symptomatic, severe, and fatal COVID-19 is recognized. There is also early evidence that vaccination can reduce the chance for long COVID-19. Nonetheless, the willingness to get vaccinated and receive booster shots remains subpar among people with neurologic disorders. Vaccine scepticism not only jeopardizes collective efforts to end the COVID-19 pandemic but puts individual lives at risk, as some chronic neurologic diseases are associated with a higher risk for an unfavorable COVID-19 course. Methods In this position paper, the NeuroCOVID-19 Task Force of the European Academy of Neurology (EAN) summarizes the current knowledge on the prognosis of COVID-19 among patients with neurologic disease, elucidates potential barriers to vaccination coverage, and formulates strategies to overcome vaccination hesitancy. A survey among the Task Force members on the phenomenon of vaccination hesitancy among people with neurologic disease supports the lines of argumentation. Results The study revealed that people with multiple sclerosis and other nervous system autoimmune disorders are most skeptical of SARS-CoV-2 vaccination. The prevailing concerns included the chance of worsening the pre-existing neurological condition, vaccination-related adverse events, and drug interaction. Conclusions The EAN NeuroCOVID-19 Task Force reinforces the key role of neurologists as advocates of COVID-19 vaccination. Neurologists need to argue in the interest of their patients about the overwhelming individual and global benefits of COVID-19 vaccination. Moreover, they need to keep on eye on this vulnerable patient group, its concerns, and the emergence of potential safety signals.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Rakusa, MartinUNSPECIFIEDorcid.org/0000-0003-4433-3985UNSPECIFIED
Ozturk, SerefnurUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Moro, ElenaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Helbok, RaimundUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bassetti, Claudio L.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Beghi, EttoreUNSPECIFIEDorcid.org/0000-0003-2542-0469UNSPECIFIED
Bereczki, DanielUNSPECIFIEDorcid.org/0000-0002-8374-0500UNSPECIFIED
Bodini, BenedettaUNSPECIFIEDorcid.org/0000-0001-8010-1220UNSPECIFIED
Di Liberto, GiovanniUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Jenkins, Thomas M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Macerollo, AntonellaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Maia, Luis F.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Martinelli-Boneschi, FilippoUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Pisani, AntonioUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Priori, AlbertoUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Sauerbier, AnnaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Soffietti, RiccardoUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Taba, PilleUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
von Oertzen, Tim J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Zedde, MarialuisaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Crean, MichaelUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Burlica, AnjaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Cavallieri, FrancescoUNSPECIFIEDorcid.org/0000-0001-5836-1982UNSPECIFIED
Sellner, JohannUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-698043
DOI: 10.1111/ene.15368
Journal or Publication Title: Eur. J. Neurol.
Volume: 29
Number: 8
Page Range: S. 2163 - 2173
Date: 2022
Publisher: WILEY
Place of Publication: HOBOKEN
ISSN: 1468-1331
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
MULTIPLE-SCLEROSIS; SARS-COV-2Multiple languages
Clinical Neurology; NeurosciencesMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/69804

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item